Abstract
BackgroundPilot studies have shown durable responses in two thirds of patients with poor prognosis diffuse cutaneous systemic sclerosis (dcSSc) treated with high dose immunosuppressive therapy and haematopoietic stem cell transplantation...
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have